| Financial Year |
March 31 2023 |
| Monetary Funds |
275,062,193.44 |
| Held-for-trading Financial Assets |
698,683.22 |
| Notes Receivable |
89,149,164.89 |
| Accounts Receivable |
575,842,913.20 |
| Advances to Suppliers |
141,205,564.31 |
| Other Receivables |
12,596,331.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
131,984,618.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,116,725.54 |
| Total Current Assets |
1,298,609,681.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
84,381,502.57 |
| Investment Properties |
-- |
| Fixed Assetes |
66,693,507.36 |
| Under-construction Projects |
283,148,152.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,918,372.99 |
| R&D expenses |
-- |
| Goodwill |
42,112,285.74 |
| Long-Term Deferred and Prepaid Expenses |
16,933,734.04 |
| Deferred Income Tax Assets |
29,808,302.22 |
| Other Non-Current Assets |
4,317,932.93 |
| Sub-Total of Non-Current Assets |
633,600,804.11 |
| Total Assets |
1,932,210,485.99 |
| Short-Term Loans |
260,522,407.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,000,000.00 |
| Accounts Payable |
149,422,919.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,175,101.66 |
| Taxes Payable |
14,081,117.04 |
| Interest Payable |
1,133,155.35 |
| Dividend Payable |
-- |
| Other payables |
38,185,481.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,734,495.18 |
| Other Current Liabilities |
8,162,084.60 |
| Sub-Total of Current Liabilities |
635,031,811.35 |
| Long-term Loans |
234,412,277.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
243,053,340.05 |
| Total Liabilities |
878,085,151.40 |
| Paid-In Capital(Or Share Stock) |
181,918,573.00 |
| Capital Surplus |
675,539,734.90 |
| Surplus Reserve |
15,953,516.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
157,538,901.99 |
| Minority Stockholder's Interest |
16,121,071.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,038,004,263.50 |
| Owner's Equity（Stockholder's Equity） |
1,054,125,334.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,932,210,485.99 |
